United States · Venture startup

Who invested in Glycostasis

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechPharma

Funding summaryUpdated 15 Nov 2026

$150Kraised across 1 round since 2015, from 1 source

Latest round
Venture, $150KJun 2015
Investors
0
See who backed them

The rounds

  1. Jun 2015
    Venture$150K

    No investor was named in the report.

    From a historical funding recordSEC filing: $150K sold, first sale May 2015

Funding filed with regulators

Glycostasis filed one raise, $150K in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. May 2015$150K1 investorequityof $2.7M offeredSEC Form D

Founders and team

From the SEC filings it signed: 1 on the team.

  • John MulliganExecutive Officer, Director, Promoteri

Quick answers about Glycostasis

How much has Glycostasis raised?

Glycostasis has raised $150K across 1 round since 2015.

When did Glycostasis last raise?

Glycostasis's most recent round was a Venture of $150K in Jun 2015.

What was Glycostasis's biggest round?

Its most recent round, $150K in Jun 2015, is also its largest on record.

What stage is Glycostasis at?

Glycostasis's latest named round is a Venture, in Jun 2015.

Where is Glycostasis based?

Glycostasis is based in the United States.

Companies like Glycostasis

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.